Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Sunrise Technology Development is a specialized chemical and pharmaceutical manufacturer based in Wuhan, China. The company focuses on the research, development, and production of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and fine chemicals. Their product portfolio is notably focused on Selective Androgen Receptor Modulators (SARMs), steroids, nootropics, and various nutritional supplements. They serve a global clientele within the pharmaceutical, biotechnology, and research sectors by providing high-purity raw materials and custom synthesis services. Located in the East Lake High-tech Development Zone, the firm operates with a focus on large-scale production and international export standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Sunrise Technology Development.